Zobrazeno 1 - 1
of 1
pro vyhledávání: '"77"'
Autor:
Tolaney SM; Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: sara_tolaney@dfci.harvard.edu., Wardley AM; The NIHR Manchester Clinical Research Facility at The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK., Zambelli S; Istituto Di Ricovero e Cura a Carattere Scientifico, Ospedale San Raffaele, IRCCS, Milano, Italy., Hilton JF; Department of Medicine, Division of Medical Oncology, The Ottawa Hospital and University of Ottawa, Ottawa, Canada., Troso-Sandoval TA; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ricci F; Institut Curie, PSL Research University, Department of Medical Oncology, Paris, France., Im SA; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea., Kim SB; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea., Johnston SR; Royal Marsden Hospital, London, UK., Chan A; Breast Cancer Research Centre-WA, Nedlands, WA, Australia; Curtin University, Nedlands, WA, Australia., Goel S; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; The Sir Peter MacCallum Department of Medical Oncology, University of Melbourne, Melbourne, VIC, Australia., Catron K; Eli Lilly, Indianapolis, IN, USA., Chapman SC; Eli Lilly, Windlesham, UK., Price GL; Eli Lilly, Indianapolis, IN, USA., Yang Z; Eli Lilly, Indianapolis, IN, USA., Gainford MC; Eli Lilly, Indianapolis, IN, USA., André F; Gustave Roussy, Université Paris Saclay, INSERM, Villejuif, France.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2020 Jun; Vol. 21 (6), pp. 763-775. Date of Electronic Publication: 2020 Apr 27.